Please login to the form below

Not currently logged in

Amylyx’s Relyvrio receives FDA approval for ALS treatment

Relyvrio was shown to significantly slow physical decline in people living with ALS

Sanofi and Regeneron’s Dupixent approved by FDA for prurigo nodularis

SanofiThe two phase 3 trials showed a meaningful reduction in itching

Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit

Biogen Idec buildingFor pursuing the case, the former employee will receive about $250m

Janssen’s Erleada combination accepted in Scotland for prostate cancer

JanssenThe combination therapy significantly improved progression-free and overall survival rates

AstraZeneca’s Tezspire receives MHRA approval as add-on treatment for severe asthma

AZ NEWTezspire demonstrated reduced annualised rate of asthma exacerbations

Pfizer and BioNTech seek FDA authorisation for COVID-19 booster for children

Pfizer NY headquartersAn application will also be submitted to the European Medicines Agency to extend the marketing authorisation for this age group

EC approves Alexion's Ultomiris as generalised myasthenia gravis treatment

Eu flag 2020 newThe positive phase 3 trial results assessing the treatment were published in NEJM Evidence

Biogen’s tofersen shows promise in rare form of ALS in new data analysis

BiogenMutations in the SOD1 gene are responsible for approximately 2% of global ALS cases

AstraZeneca’s Tezspire receives EC approval as severe asthma add-on treatment

AZ NEWTezspire demonstrated superiority across every primary and key secondary endpoint compared to placebo

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Subscribe to our email news alerts

Featured jobs


Add my company

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....